HOME >> BIOLOGY >> NEWS
Certain blood pressure-lowering drugs reduce diabetes risk in Hispanic patients

atients from 14 countries - including about 8,000 Hispanics - for two to five years. The study enrolled more Hispanic patients than any other hypertension trial to date, Cooper-DeHoff said, and included Hispanic participants from the mainland United States, Puerto Rico, Cuba, Mexico, Canada, Guatemala, Panama and El Salvador.

Participants were randomly assigned to receive a sustained-release form of the calcium antagonist verapamil or the beta-blocker atenolol. Both groups also could receive the ACE inhibitor trandolapril and the diuretic hydrochlorothiazide.

Researchers found that both treatment strategies controlled high blood pressure exceptionally well, safely lowering it below 140/90 in 72 percent of INVEST participants, who were mostly elderly. On average, it took at least two medications to lower blood pressure in Hispanic patients, compared with three in non-Hispanic patients.

Overall, Hispanic patients had a 19 percent increased risk of developing diabetes during the study's follow-up period, but those in the verapamil group were actually 15 percent less likely to develop diabetes, and the addition of trandolapril to verapamil was linked to the decreased risk.

UF researchers said that one or two out of every 100 hypertensive heart disease patients treated with a verapamil SR-trandolapril strategy for at least three years could potentially avoid diabetes - an advance that would affect thousands.

Use of ACE inhibitors has been shown to improve the body's ability to use sugar for fuel, Cooper-DeHoff said.

"Because trandolapril was used more frequently in verapamil strategy, this is likely why we saw a reduced rate of new diabetes," she said, adding that preventing diabetes would have tremendous public health implications and could greatly cut related health-care costs.

UF researchers also will continue to analyze DNA they have collected from Hispanic study participants to evaluate the role of genes and
'"/>

Contact: Melanie Fridll Ross
ufcardiac@aol.com
352-690-7051
University of Florida
22-May-2006


Page: 1 2 3

Related biology news :

1. Certain gene variation associated with better mobility for older individuals who exercise
2. Certain fish have a special mating preference
3. Certain genetic test helps detect mutations that may be missed by conventional DNA test
4. High blood pressure, low energy -- a recipe for heart failure
5. Brain blood flow gives clues to treating depression
6. Study finds gender differences in renal and other genes contributing to blood pressure
7. Study suggests estrogen deficiency can lead to obesity-induced high blood pressure after menopause
8. Research aims to identify markers for menopausal women at risk for deadly blood clot
9. Teamwork between 2 key proteins necessary for normal development and regulation of red blood cells
10. A low expression of MX2 gene exists in the white blood cells of narcoleptics
11. How a pain in the neck could be bad for your blood pressure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2021)... ... March 25, 2021 , ... Phlexglobal announced ... Planet Group, has selected Phlexglobal and its innovative regulatory SaaS software, PhlexSubmission, as ... a comprehensive review of five regulatory software companies, with the review team including ...
(Date:3/27/2021)... ... 25, 2021 , ... The 2021 Virtual Conference on Clinical Trial Supply-Europe ... More and more, clinical trial supply conferences are featuring speakers and forums that ... Asymmetrex’s founder and CEO, James L. Sherley, M.D., Ph.D., presented a talk ...
(Date:3/23/2021)... ... March 23, 2021 , ... G-CON Manufacturing (G-CON), the ... by Matica Biotechnology (Matica Bio), a contract development and manufacturing organization (CDMO) specializing ... the cleanroom build out for its new GMP production facility in College Station, ...
Breaking Biology News(10 mins):
(Date:3/27/2021)... ... March 24, 2021 , ... ... Life Sciences and Healthcare firms of all sizes, adds depth to its team ... specialist. Pardillo, who earned his doctorate in computational chemistry from Florida International University ...
(Date:3/27/2021)... ... March 24, 2021 , ... ABI Wellness, ... and reporting approach designed under CEO Mark Watson, today announced a webinar dedicated ... featuring guest speakers Dr. Cameron Clark, Neuropsychologist and Founder of Sharp Thinking, and ...
(Date:3/27/2021)... ... ... The Xtalks editorial team is pleased to announce the launch of the ... joined by editorial team members Ayesha Rashid, Sydney Perelmutter and Mira Nabulsi to discuss ... including insights from industry experts. , The Xtalks Life Science podcast will feature ...
(Date:3/23/2021)... Conn. (PRWEB) , ... March 23, 2021 , ... ... develops solutions for characterizing microbiome populations down to the strain level, recently unveiled ... applications. , Not all microbes are created equal: some are easy to ...
Breaking Biology Technology:
Cached News: